基本信息
浏览量:128
职业迁徙
个人简介
Dr. Aikawa is a passionate advocate for the early imaging and treatment of calcific aortic valve disease. Dr. Aikawa’s Research Program focuses on the development of new therapies to prevent, treat and cure calcific aortic valve stenosis, a disease that currently has no treatment options other than valve replacement. She was at the forefront in the discovery of inflammation-dependent mechanisms of cardiovascular calcification. Her studies contributed to the discovery of calcifying extracellular vesicles (exosomes) as a precursor of microcalcification. More recently she used systems approaches, involving multi-omics and network medicine, to identify novel therapeutic targets.
研究兴趣
论文共 426 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Imke Jansen,Rachel Cahalane, Ranmadusha Hengst,Ali Akyildiz,Eric Farrell,Frank Gijsen,Elena Aikawa, Kim van der Heiden, Tamar Wissing
Circulation researchno. 2 (2024): 186-188
Sneha Raju,Steven R. Botts, Mark C. Blaser, Majed Abdul-Samad,Kamalben Prajapati,Negar Khosraviani, Tse Wing Winnie Ho, Leandro C. D. Breda,Crizza Ching,Natalie J. Galant, Lindsey Fiddes,Ruilin Wu,
CIRCULATION RESEARCHno. 3 (2024): 269-289
CIRCULATIONno. 5 (2024): 391-401
Leslie B. Gordon,Leslie B. Gordon,Leslie B. Gordon,Sammy Basso,Sammy Basso,Sammy Basso,Sammy Basso, Justine Maestranzi,Elena Aikawa,Cassandra L. Clift, Antonio Giovanni Cammardella,Tommaso Hinna Danesi,
Frontiers in Cardiovascular Medicine (2024)
CIRCULATION RESEARCHno. 2 (2024): 186-188
bioRxiv (Cold Spring Harbor Laboratory)no. 9 (2024): eadj9793-eadj9793
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYno. 3 (2024): 584-602
Mark C. Blaser, Daniel Reichart,Abhijeet Sonawane,Florian Schlotter,Arda Halu, Livia Silva A. Passos,Daniel DeLaughter,Wunan Zhou,Ron Blankstein,Marcelo Di Carli, Maria D. Nunes, Marie Billaud,
Arteriosclerosis, Thrombosis, and Vascular Biologyno. Suppl_1 (2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn